Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 8, 2026, AdaptHealth Corp. (AHCO) has a Wall Street consensus price target of $12.00, based on estimates from 12 covering analysts. With the stock currently trading at $11.73, this represents a potential upside of +2.3%. The company has a market capitalization of $1.59B.
Analyst price targets range from a low of $11.00 to a high of $13.00, representing a 17% spread in expectations. The median target of $12.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 9 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, AHCO trades at a trailing P/E of -22.6x and forward P/E of 11.7x. Analysts expect EPS to grow +270.3% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonQuick answers to the most common questions about buying AHCO stock.
The consensus price target for AHCO is $12, close to the current price of $11.73 (2.3% implied move). Based on 12 analyst estimates, the stock appears fairly valued near current levels.
AHCO has a consensus rating of "Buy" based on 12 Wall Street analysts. The rating breakdown is predominantly bullish, with 9 Buy/Strong Buy ratings. The consensus 12-month price target of $12 implies 2.3% upside from current levels.
With a forward P/E of 11.7453x, AHCO trades at a relatively low valuation. The consensus target of $12 implies 2.3% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $13 for AHCO, while the most conservative target is $11. The consensus of $12 represents the median expectation. These targets typically reflect 12-month expectations.
AHCO is moderately covered, with 12 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 9 have Buy ratings, 2 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AHCO stock forecast based on 12 Wall Street analysts shows a consensus price target of $12, with estimates ranging from $11 (bear case) to $13 (bull case). The median consensus rating is "Buy".
AHCO trades at a forward P/E ratio of 11.7x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
AHCO appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $12 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AHCO analyst price targets range from $11 to $13, a 17% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $12 consensus represents the middle ground.